Epilepsia Open
77 FOLLOWERS
Epilepsia Open is the open-access journal of the ILAE. Epilepsia Open publishes rigorous basic and clinical epilepsy research or critical reviews aiming to promote the dissemination, transparency, translatability, and implementation of epilepsy research advances.
Epilepsia Open
4d ago
Abstract
Epilepsy is the most common chronic neurological disease, affecting nearly 1%–2% of the world's population. Current pharmacological treatment and regimen adjustments are aimed at controlling seizures; however, they are ineffective in one-third of the patients. Although neuronal hyperexcitability was previously thought to be mainly due to ion channel alterations, current research has revealed other contributing molecular pathways, including processes involved in cellular signaling, energy metabolism, protein synthesis, axon guidance, inflammation, and others. Some forms of drug-resista ..read more
Epilepsia Open
4d ago
Abstract
The mechanisms causing new onset refractory status epilepticus (NORSE) are often unknown. Recently, a seasonal variation with NORSE peaking during the summer was described in a mixed cohort of adults and children why we here studied the seasonal variation in a Danish status epilepticus (SE) cohort. This retrospective cohort study comprised SE patients aged ≥18 diagnosed and treated 2008–2017 at the Odense University Hospital. Clinical characteristics and seasonality of patients fulfilling the diagnostic criteria for NORSE were compared with patients with refractory SE (RSE) due to oth ..read more
Epilepsia Open
6d ago
Abstract Objective
We studied the impact of depressive symptoms on adverse effects (AEs) in people with epilepsy (PWE) on antiseizure medication (ASM) therapy. An effect of depression on the AE burden has already been reported. We studied the correlation of various depressive symptoms with specific AEs to assess which AEs are especially prone to being confounded by particular depressive symptoms.
Methods
PWE filled in a variety of questionnaires including the “Neurological Disorder Depression Inventory for Epilepsy” (NDDI-E), “Emotional Thermometers 4” (ET4) and “Liverpool Adverse Events Profi ..read more
Epilepsia Open
1w ago
Abstract Objective
To assess asymptomatic rates and severity of SARS-CoV-2 infection in people with epilepsy and their healthcare workers in a long-term care facility which had implemented weekly surveillance testing between April 2020 and June 2022.
Methods
Questionnaires focused on objective and subjective COVID-19 symptoms for people with epilepsy residing in and their healthcare workers at the Chalfont Centre for Epilepsy in June 2022. Demographic information, comorbidities, and seizure frequency were gathered from medical records. We also collected responses on objective and subjective CO ..read more
Epilepsia Open
1w ago
Abstract Objective
Relapse of epileptic spasms after initial treatment of infantile epileptic spasms syndrome (IESS) is common. However, past studies of small cohorts have inconsistently linked relapse risk to etiology, treatment modality, and EEG features upon response. Using a large single-center IESS cohort, we set out to quantify the risk of epileptic spasms relapse and identify specific risk factors.
Methods
We identified all children with epileptic spasms at our center using a clinical EEG database. Using the electronic medical record, we confirmed IESS syndrome classification and ascert ..read more
Epilepsia Open
2w ago
This study aimed to evaluate the efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with focal-onset seizures. The efficacy, safety, and tolerability profiles were consistent with brivaracetam studies in predominantly non-Asian populations, demonstrating that adjunctive brivaracetam was efficacious and well-tolerated in adult Asian patients with focal-onset seizures.
Abstract Objective
Evaluate efficacy, safety, and tolerability of adjunctive brivaracetam (BRV) in adult Asian patients with focal-onset seizures (FOS).
Methods
Phase III, randomized, double-bl ..read more
Epilepsia Open
2w ago
Abstract Objective
Cenobamate is an antiseizure medication (ASM) associated with high rates of seizure freedom and acceptable tolerability in patients with focal seizures. To achieve the optimal cenobamate dose for maximal potential effectiveness while avoiding or minimizing drug-related adverse events (AEs), the administration of cenobamate with other ASMs must be managed through concomitant ASM load reduction. A panel of Spanish epilepsy experts aimed to provide a Spanish consensus on how to adjust the dose of concomitant ASMs in patients with drug-resistant epilepsy (DRE) in order to improv ..read more
Epilepsia Open
3w ago
Abstract
Variants in potassium channel-related genes are one of the most important mechanisms underlying abnormal neuronal excitation and disturbances in the cellular resting membrane potential. These variants can cause different forms of epilepsy, which can seriously affect the physical and mental health of patients, especially those with refractory epilepsy or status epilepticus, which are common among pediatric patients and are potentially life-threatening. Variants in potassium ion channel-related genes have been reported in few studies; however, to our knowledge, no systematic review has ..read more